CI - Cigna Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
182.31
+0.55 (+0.30%)
As of 9:43AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close181.76
Open181.27
Bid181.20 x 1100
Ask184.00 x 900
Day's Range181.27 - 182.80
52 Week Range163.02 - 227.13
Volume148,837
Avg. Volume2,149,159
Market Cap44.368B
Beta0.77
PE Ratio (TTM)17.78
EPS (TTM)10.26
Earnings DateNov 1, 2018
Forward Dividend & Yield0.04 (0.02%)
Ex-Dividend Date2018-03-09
1y Target Est222.59
Trade prices are not sourced from all markets
  • Icahn won't solicit votes against Cigna-Express Scripts deal
    American City Business Journals47 minutes ago

    Icahn won't solicit votes against Cigna-Express Scripts deal

    The octogenarian investor originally opposed the deal due to the competitive risk Express Scripts and Cigna now face from Amazon.

  • Icahn ends Cigna-Express Scripts campaign, shares bounce
    Associated Press1 hour ago

    Icahn ends Cigna-Express Scripts campaign, shares bounce

    Shares of Express Scripts are moving higher before the opening bell after activist investor Carl Icahn ended a short-lived fight to scuttle Cigna's takeover of the pharmacy benefit manager. Icahn said late Monday that he'll end his campaign to convince Cigna shareholders to vote against the roughly $52-billion deal this month. Icahn argued in a lengthy letter to fellow shareholders last week that Cigna was "dramatically overpaying" for Express Scripts.

  • Icahn abandons fight against Express Scripts-Cigna deal
    American City Business Journals2 hours ago

    Icahn abandons fight against Express Scripts-Cigna deal

    Investor Carl Icahn will stop his efforts to fight Cigna's pending $54 billion acquisition of St. Louis-based Express Scripts Holding Co.

  • TheStreet.com3 hours ago

    Tesla and Musk, Cigna and Icahn, Home Depot, McDonald's - 5 Things You Must Know

    U.S. stock futures rose on Tuesday, Aug. 14, as investors cautiously returned to risk markets amid a stabilization in Turkey's currency crisis. Turkey's lira, which has been at the center of a one-week currency crisis that has rippled through financial markets all over the world, gained around 3% against the U.S. dollar in overnight trading. Indications were that moves by Turkey's central bank to stem the lira's decline likely will hold the currency in place while President Recep Tayyip Erdoğan negotiates the potential release of the American evangelical pastor Andrew Brunson, whom Ankara has accused of being involved in a failed 2016 coup.

  • Financial Times3 hours ago

    [$$] Carl Icahn backs down over opposition to Cigna-Express Scripts deal

    to Cigna’s $67bn acquisition of Express Scripts, only a week after launching a withering attack that branded the deal “inexplicably ridiculous”. Mr Icahn’s climbdown ahead of a shareholder vote on August 24 follows expressions of support for the deal from the influential proxy advisers ISS and Glass Lewis, as well as backing for the takeover from Larry Robbins’s Glenview Capital Management hedge fund. Previously short Express Scripts stock, Mr Icahn said last week that “the only shareholders we believe would vote for this very risky acquisition are those who also own Express Scripts and are desperate to save it even at the expense of losing a great deal of value in their Cigna investment”.

  • Reuters9 hours ago

    PRESS DIGEST- Wall Street Journal - Aug 14

    The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Elon Musk said Saudi Arabia's sovereign-wealth fund has approached ...

  • Thomson Reuters StreetEvents10 hours ago

    Edited Transcript of CI earnings conference call or presentation 2-Aug-18 12:30pm GMT

    Q2 2018 Cigna Corp Earnings Call

  • The Wall Street Journal11 hours ago

    [$$] Icahn Backs Down on Cigna-Express Scripts Deal

    Carl Icahn no longer plans to solicit votes from Cigna Corp. shareholders against the health insurer’s $54 billion deal to buy Express Scripts Holding Co. after two proxy-advisory firms recommended shareholders support the deal, the billionaire activist investor said in a statement Monday. It called his opposition “misguided and shortsighted” in a statement last week.

  • Reuters13 hours ago

    Icahn reverses position on Cigna-Express Scripts deal

    Icahn's comments come after proxy advisory firms Glass Lewis & Co and Institutional Shareholder Services Inc (ISS), as well as hedge fund Glenview Capital Management, extended their support for the deal. "In light of the ISS and Glass Lewis recommendations in favor of the Cigna/Express Scripts transaction and the significant stockholder overlap between the two companies, we have informed the SEC (U.S. Securities and Exchange Commission) that we no longer intend to solicit proxies to vote against the transaction," Icahn said in a statement. The billionaire investor, who has a long position on Cigna and a short position on Express Scripts, has been vocal in his criticism of the deal and last week said Cigna (CI.N) was overpaying for Express Scripts (ESRX.O).

  • Icahn reverses position on Cigna-Express Scripts deal
    Reuters13 hours ago

    Icahn reverses position on Cigna-Express Scripts deal

    Icahn's comments come after proxy advisory firms Glass Lewis & Co and Institutional Shareholder Services Inc (ISS), as well as hedge fund Glenview Capital Management, extended their support for the deal. "In light of the ISS and Glass Lewis recommendations in favour of the Cigna/Express Scripts transaction and the significant stockholder overlap between the two companies, we have informed the SEC (U.S. Securities and Exchange Commission) that we no longer intend to solicit proxies to vote against the transaction," Icahn said in a statement.

  • Bloomberg14 hours ago

    Icahn Drops Fight to Block Cigna's Express Scripts Takeover

    Activist investor Carl Icahn has dropped his fight to block Cigna Corp.’s $54 billion acquisition of Express Scripts Holding Co. after two prominent shareholder advisory firms came out in support of the deal. Institutional Shareholder Services Inc. and Glass Lewis & Co. last week urged Cigna’s investors to support the takeover, saying it made sense from a financial and strategic perspective. Icahn had opposed the deal, saying it would be a “travesty” if it were to proceed.

  • Express Scripts-Cigna pending merger praised by proxy advisory firms
    American City Business Journalsyesterday

    Express Scripts-Cigna pending merger praised by proxy advisory firms

    Two proxy advisory firms have recommended that Express Scripts' and Cigna's shareholders vote in favor of their pending $54 billion merger.

  • Yahoo Finance Live: Market Movers - Tuesday, August 14
    Yahoo Finance Video2 hours ago

    Yahoo Finance Live: Market Movers - Tuesday, August 14

    Yahoo Finance's LIVE stock market coverage and analysis.

  • Icahn drops fight against Cigna-Express Scripts deal
    CNBC Videos3 hours ago

    Icahn drops fight against Cigna-Express Scripts deal

    Carl Icahn dropped his fight against the Cigna-Express Scripts deal citing the crossover was too big.